Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
gptkb:Phillip_Frost
|
| gptkbp:focus |
gptkb:biotechnology
diagnostics pharmaceutical development |
| gptkbp:founded |
1991
|
| gptkbp:founder |
gptkb:Phillip_Frost
|
| gptkbp:headquartersLocation |
gptkb:Miami,_Florida,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
OPKO Health
|
| gptkbp:industry |
healthcare
pharmaceuticals |
| gptkbp:ISIN |
US68375N1037
|
| gptkbp:numberOfEmployees |
over 5000
|
| gptkbp:product |
gptkb:4Kscore_Test
gptkb:Rayaldee |
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:OPK
|
| gptkbp:subsidiary |
gptkb:BioReference_Laboratories
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
https://www.opko.com/
|
| gptkbp:bfsParent |
gptkb:Phillip_Frost
gptkb:ModeX_Therapeutics gptkb:BioReference_Laboratories |
| gptkbp:bfsLayer |
6
|